What You Need To Know About The FDA-Approved Drug For Alzheimer's

The video discusses Aducanumab, a drug for Alzheimer's, highlighting its insurance coverage issues, efficacy, and FDA approval. It explains the eligibility criteria for patients, the drug's administration method, and its mechanism of action. The video also covers potential side effects and the ongoing studies to evaluate the drug's effectiveness, with a possibility of it being removed from the market if future data is unfavorable.

What is the significance of amyloid plaques in Alzheimer's disease?

What is the FDA's current stance on the drug aducanumab?